MPM closes $550m fourth fund

The US-German investment house’s latest life sciences-focused fund will invest principally in US biotechnology companies.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this